Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Ixekizumab and Malignant Neoplasms: A Pooled Analysis of Data From 25 Randomized Clinical Trials.
Journal: JAMA dermatology
Published: July 09, 2025
Long-Term Safety of Ixekizumab Treatment in Patients with Psoriasis, Psoriatic Arthritis, or Axial Spondyloarthritis: a Post Hoc Analysis of Cerebro-Cardiovascular Events.
Journal: Dermatology and therapy
Published: October 02, 2024
Treatment-emergent Candida infections in patients with psoriasis, psoriatic arthritis, and axial spondyloarthritis treated with ixekizumab: an integrated safety analysis of 25 clinical studies.
Journal: Expert opinion on drug safety
Published: September 05, 2024
Long-term safety of Ixekizumab in adults with psoriasis, psoriatic arthritis, or axial spondyloarthritis: a post-hoc analysis of final safety data from 25 randomized clinical trials.
Journal: Arthritis research & therapy
Published: September 25, 2023
Increased risk of severe generalized pustular psoriasis due to tuberculosis screening delay for spesolimab initiation.
Journal: Journal of the American Academy of Dermatology
Published: July 28, 2023
Vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis: Delphi consensus from the medical board of the National Psoriasis Foundation.
Journal: Journal of the American Academy of Dermatology
Published: May 25, 2023
Full Guidelines-From the Medical Board of the National Psoriasis Foundation: Perioperative management of systemic immunomodulatory agents in patients with psoriasis and psoriatic arthritis.
Journal: Journal of the American Academy of Dermatology
Published: May 19, 2023
Management of Concomitant Inflammatory Bowel Disease or Uveitis in Patients with Psoriatic Arthritis: An Updated Review Informing the 2021 GRAPPA Treatment Recommendations.
Journal: The Journal of rheumatology
Published: June 28, 2022
Effectiveness and safety of intravenous golimumab with and without concomitant methotrexate in patients with rheumatoid arthritis in the prospective, noninterventional AWARE study.
Journal: BMC rheumatology
Published: May 23, 2022
Responses to Ixekizumab in Male and Female Patients with Psoriatic Arthritis: Results from Two Randomized, Phase 3 Clinical Trials.
Journal: Rheumatology and therapy
Published: January 21, 2022
Last Updated: 09/26/2026